Accueil › Cancer de l'endomètre › Pennsylvanie › Philadelphia
Essais cliniques pour Cancer de l'endomètre à Philadelphia, PA
28 études pour Cancer de l'endomètre recherchent des participants dans et autour de Philadelphia (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Recrutement en coursPhase 3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · à 13 mi
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Recrutement en coursPhase 2
- Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- et 4 autres
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recrutement en coursPhase 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Recrutement en coursPhase 1
- NRG Oncology, Philadelphia
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Recrutement en coursPhase 1
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
Study of AVZO-021 in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Avenzo Therapeutics Recruiting Site, Philadelphia
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Recrutement en coursPhase 2
- UPMC Hillman Cancer Center - Part of Frick Hospital, Mount Pleasant · à 8 mi
DESTINY-PANTUMOUR04
Recrutement en coursÉtude observationnelle
- Research Site, Philadelphia
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Recrutement en coursPhase 1
- Research Site, Philadelphia
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Recrutement en coursPhase 2
- Thomas Jefferson University, Philadelphia
- Lankenau Medical Center, Wynnewood · à 7 mi
- Asplundh Cancer Pavilion, Willow Grove · à 13 mi
- et 1 autres
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Recrutement en coursPhase 1/2
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Recrutement en coursPhase 3
- Hospital of the University of Pennsylvania ( Site 5007), Philadelphia
PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
Recrutement en coursPhase 2
- University of Pennsylvania, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Recrutement en coursÉtude observationnelle
- University of Pennsylvania, Philadelphia
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Recrutement en coursPhase 3
- Research Site, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Recrutement en coursPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Recrutement en coursPhase 1
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Recrutement en coursPhase 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Recrutement en coursPhase 1
- SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Recrutement en coursPhase 1
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Recrutement en coursPhase 3
- Research Site, Philadelphia
- Research Site, Willow Grove · à 13 mi
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Recrutement en coursPhase 1
- Sidney Kimmel Cancer Center, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Recrutement en coursPhase 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer
Recrutement en coursPhase 1 précoce
- Abramson Cancer Center at Penn Medicine, Philadelphia
- University of Pennsylvania Gynecologic Oncology Department, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Philadelphia
Essais pour Cancer de l'endomètre dans d'autres villes
- Houston, TX68 études
- New York City, NY52 études
- Boston, MA50 études
- Arlington, VA39 études
- Nashville, TN38 études
- Los Angeles, CA34 études
- St. Louis, MO29 études
- San Antonio, TX27 études
- Columbus, OH25 études
- Oklahoma City, OK25 études
- Chicago, IL25 études
- Queens, NY25 études
Autres études à Philadelphia
- Cancer (tous types)59 études
- Cancer du sein56 études
- Cancer du poumon non à petites cellules51 études
- Cancer métastatique46 études
- Cancer de la prostate44 études
- Cancer colorectal44 études
- Cancer de l'ovaire44 études
- Cancer du poumon36 études
- Leucémie aiguë myéloïde34 études
- Insuffisance cardiaque31 études
- Dépression26 études
- Cancer du pancréas26 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.